期刊文献+

肺癌患者外周血中CD+8CD2-28及CD+4CDhigh25CDlow127调节性T细胞的表达及其临床意义 被引量:1

Expression and clinical significance of CD+8CD-28andCD+4CDhigh25CDlow127 regulatory T cells in peripheralblood of lung cancer patients
原文传递
导出
摘要 目的观察肺癌患者外周血CD+8CD2-28及CD+4CDhigh25CDlow127协调节性T(Treg)细胞的表达水平,并对CD[CD;8和CD+4CDhigh25CDlow127Treg细胞行CD+8CD2+28、CD+8CD2-28及CD+4CDhigh25CDlow127调Treg细胞的表达率,以60名健康体检者作为对照,分析各指标与肺癌生物学及临床特征之间的关系。结果肺癌组cD嘻C跽T细胞[(58.430±15.749)%]和CD+4CDhigh25CDlow127Treg细胞[(7.365±2.025)%]表达均分别显著高于对照组的(41.057±15.436)%、(6.648±1.669)%,差异有统计学意义(t=6.102,P〈0.05;t=2.115,P〈0.05)。肺癌组CD+8CD2+28T细胞表达[(41.570±15.739)%]低于对照组[(58.700±15.298)%],差异有统计学意义(t=-6.043,P〈0.05)。上述三个指标的表达一与.性别、年龄及病理学类型无关(P〉0.05)。随着TNM分期增加,CD+4CDhigh25CDlow127Treg细胞表达逐渐升高,其中Ⅳ期和Ⅲ。期之间差异有统计学意义(t=3.898,P〈0.05)。而CD+8CD2-28、CD+8CD2+28T细胞的表达与临床分期无关(P〉0.05)。CD+8CD2-28与CD+4CDhigh25CDlow127Treg细胞的表达无线性相关(r=-0.169,P〉0.05)。结论CD+8CD2-28、CD+4CDhigh25CDlow127Treg细胞在肺癌患者外周血呈高表达,CD+8CD+28,T细胞呈低表达,这可能是肺癌患者免疫功能低下的原因之一。CD+8CD-28,与CD+4CDhigh25CDlow127Treg细胞之间无相关性,但两者联合检测可对了解肺癌患者免疫功能,并为肺癌寻找特异性免疫治疗及预后评价提供新的参考。 Objective To observe the changes of CD+8CD-28, CD+8CD+28 and CD+4CDhigh25CDlow127 regulate T (Treg) cellsin peripheral blood of lung cancer patients, and to analyze the correlation between CD+8CD-28 and CDCD+4CDhigh25CDlow127 Treg cells to reveal the role and clinical significance of them in lung cancer patients, Methods Flow CD+4CDhigh25CDlow127 Treg ceils in peripheral cytometry was applied to evaluate the level ofCD+8CD-28,CD+8CD+28 and CD+4CDhigh25CDlow127 Treg blood of 60 untreated lung cancer patients and 60 healthy controls group. The association of each term with clinical features was analyzed. Results The percentage of CD+8CD-28andCD+4CDhigh25CDlow127 Treg cells in lung cancer group [(58.430+15.749) %,(7.365+2.025) %] was significantly higher than those in healthy group [(41.057±15.436) %,(6.648±1.669) %,(t=6.102,P〈0.05;t=2.115,P〈0.05)], while the percentage of CD+8CD+28cells is lower (41.570±15.739)% than that in healthy group [(58.700±15.298) %,( t=-6.043,P〈0.05)]. No close associations were found between three index and gender, age, and biological characteristics. With the increase of TNM stage, The percentage of CD+4CDhigh25CDlow127 Treg cells increased gradually, which was remarkably higher in patients with stage 1V than that with stage Ilia (t=-3.898,P〈0.05). The percentage of CD+4CDhigh25CDlow127Treg cells was uncorrelated with CD+8CD-28 cells (r=-0.169,P〉0.05). Conclusion The higher percentage of CD+8CD-28andCD+4CDhigh25CDlow127 Treg cells, the lower percentage of CD+8CD+28cells may be the important reasons of immune suppression in lung cancer patients. Though there is no correlation between CD+8CD-28andCD+4CDhigh25CDlow127 Treg cells, it is may be helpful to understand immunologic function and it may look for more specific therapy and provide a new reference in the prognosis of lung cancer.
出处 《肿瘤研究与临床》 CAS 2012年第6期376-379,共4页 Cancer Research and Clinic
关键词 肺肿瘤 抗原 T淋巴细胞 调节性 Lung neoplasms Antigens T-lymphocytes, regulatory
  • 相关文献

参考文献15

  • 1Krant MJ, Manskopf G, Brandrui CS, et al. Immunologic alteration in bronchogenic cancer. Cancer, 1968, 21:623-631.
  • 2Rina P,Rndd CE. CD2s co-signaling in the adaptive immune response. Self Nonself, 2010, 1:231-240.
  • 3Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing I L-2 receptor alpha- chains:breakdown of a single mechanism of self-olerance causes various autoimmune disease. J Immunol, 1995, 155:1151-1164.
  • 4Hartigan-O' Connor DJ, Poon C, Sinclair E, et al. Human CD4 regulatory T ceils express lower levels of the L7 receptor alpha chain, allowing consistent identification and sorting of live cells. J Immunol Methods, 2007,319:41-52.
  • 5史晓宇,刘富才,苏文.肺癌患者外周血CD4^+CD25^HiCD127^Lo调节性T细胞检测的临床意义[J].肿瘤研究与临床,2009,21(7):453-454. 被引量:3
  • 6Meloni F, Morosini M, Solari N, et al. Foxp3 expressing CDCD and CDCDh T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol, 2006, 67:1-12.
  • 7Filaci G, Suciu-Foca N. CDsuppressor cells are back to the game:arethey players in autoimmunity. Autoimmun Rev, 2002,1:279-283.
  • 8Getachew Y, Stout-Delgado H, Miller BC, et al. Granzyme C supports efficient CTL-mediated killing late in primary alloimmune responses. J Immunol, 2008, 181:7810-7817.
  • 9Filaci G, Fravega M, Negrini S, et al. Nonantigen specific C T suppressor lymphocytes originate from CDCD T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol, 2004, 65:142- 156.
  • 10翟晋芳(综述),韩福才(审校).CD4^+CD25^+调节性T细胞与肿瘤的相关性研究[J].肿瘤研究与临床,2009,21(3):205-207. 被引量:6

二级参考文献32

  • 1Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25. Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 1995, 155:1151-1164.
  • 2Vigouroux S, Yvon E, Biagi E, et al. Antigen-induced regula tory T cells. Blood, 2004, 104: 26-33.
  • 3Muller A J, Scherle PA. Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors. Nat Rev Cancer, 2006, 6: 613-625.
  • 4Khazaie K, Von Boehmer H. The impact of CD: CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer. Semin Cancer Biol, 2006, 16: 124-136.
  • 5Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD 4+ CD25+ regulatory T cells. Nat Immunol, 2003, 4: 330-336.
  • 6Kiniwa Y, Miyahara Y, Wang HY, et al. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res, 2007.13: 6947-6958.
  • 7Paust S, Lu L, McCarty N, et al. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A, 2004, 101: 10398-10403.
  • 8Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol, 2004, 4: 762-774.
  • 9Maloy KJ, Salaun L, Cahill R, et al, CD4+ CD25+ Treg suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med, 2003, 197: 111-119.
  • 10Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4+ CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor. J Exp Med, 2001, 194: 629-644.

共引文献7

同被引文献5

  • 1McCabe MP, Smyth MP, Richardson DR. Current concept review: vitamin D and stress fractures[J]. Foot Ankle Int,2012,33 (6) :526-533.
  • 2Grant WB. Does solar ultraviolet irradiation affect cancer mortality rates in China[J]. Asian Pac J Cancer Prev,2007,8(2) :236-242.
  • 3Mohr SB, Garland CF, Gorham ED, et al. Could ultraviolet B irra- diance and vitamin D be associated with lower incidence rates of lung cancer? [ J]. J Epidemiol Community Health,2008,62( 1 ) :69-74.
  • 4Jcremy A, Goettel, Holly M, Scott Algood, et al. KSRI protects from interleukin-10 deficiency-induced colitis in mice by suppressing T lymphocyte interfemn-/ production [ J ] . Gastroenterology, 2011,140 ( 1 ) : 265-274.
  • 5华军,魏云玉.消化道恶性肿瘤患者CD4^+ CD25^+ Treg的检测及意义[J].放射免疫学杂志,2010,23(5):553-555. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部